Hyus Meditec

Established in 2020 and based in Shenzhen, China, Hyus Meditec operates as a biomedical ultrasound products developer that focuses on ICE intra-cardiac ultrasound catheters R&D. Qiu Weibao, the founder of the company, and he is the deputy director of Medical Imaging Technology and Equipment Engineering Laboratory of Chinese Academy of Sciences and director of Shenzhen Key Laboratory of Ultrasound Imaging and Therapy Technology. The core research team comes from Chinese Academy of Sciences. In May 2025, it closed a venture funding led by returning investor Nanshan Venture Capital, with participation from another returning investor State Science & Technology Investment.

The company provides medical equipment and consumables products, including high-resolution color ultrasound, intracardiac interventional ultrasound catheter and non-contact high-precision ultrasound pipetting. Its platforms include high-end ultrasound transducers, active interventional catheters, ultrasound imaging algorithms and ultrasound host devices. The company has 50MHz UHF ultrasound imaging mainframe and interventional endoscopic ultrasound imaging mainframe equipment production lines. The company generates revenue by selling equipment and consumables such as high-resolution color ultrasound, intracardiac interventional ultrasound catheters, and non-contact high-precision ultrasonic pipetting.